Background illustration for clinical trials search

Oncology Clinical Trials

Browse 9,272 oncology clinical trials enrolling across the United States and Canada. 218 people applied to oncology studies last month. Search by city or state to find one near you.

Filter
1
Active & Responsive

Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL

for
Hodgkin Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 2 - 21

Code: NCT07551583

Phase 2, Recruiting
Active & Responsive

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

for
Relapsed or Refractory Multiple Myeloma
Location: Houston TX, Duarte CA
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07681596

Phase 1, Phase 2, Recruiting
Active & Responsive

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

for
Parkinson Disease, Prodromal Stage, Neurodegenerative Diseases,
Location: Rochester NY
Sponsor: Radboud University Medical Center

Sex: All

Age: 50+

Code: NCT06993142

Recruiting
Active & Responsive

Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)

for
Melanoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06683755

Phase 1, Phase 2, Recruiting
Active & Responsive

Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention

for
Sarcoma, Bone Sarcoma, Soft Tissue Sarcoma (STS)
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 15 - 39

Code: NCT07662239

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

CHAMPION: Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSM

for
PrEP Adherence, Methamphetamine Use Disorder, HIV
Location: San Francisco CA
Sponsor: University of California, San Diego

Sex: Male

Age: 18 - 40

Code: NCT07213258

Recruiting
Active & Responsive

Accelerated Neuromodulation Therapy and Neurocomputational Biomarkers in Individuals at Clinical High Risk for Psychosis

for
Clinical High Risk for Psychosis (CHR), Psychotic Disorders,
Location: Verdun
Sponsor: Douglas Mental Health University Institute

Sex: All

Age: 18 - 34

Code: NCT07786714

Recruiting
Active & Responsive

Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer

for
Resectable Pancreatic Ductal Adenocarcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07645651

Phase 1, Recruiting
Active & Responsive

Small Trial of Alendronate Impact on the Reservoir of HIV

for
HIV
Location: Pittsburgh PA, Columbus OH, Aurora CO, San Francisco CA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 65

Code: NCT07216794

Phase 2, Recruiting
Active & Responsive

Comparative Self-collection for Cervical Cancer Screening Pivotal Study

for
HPV, HPV - Anogenital Human Papilloma Virus Infection
Location: Wilmington NC, Raleigh NC, Lake Worth FL,
Sponsor: Mel Mont Medical

Sex: Female

Age: 25 - 65

Code: NCT07758140

Recruiting
Active & Responsive

ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection

for
Clostridium Difficile Infection Recurrence
Location: Hamden CT, Massapequa NY, Coral Gables FL,
Sponsor: Acurx Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07513285

Phase 2, Recruiting
Active & Responsive

A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy

for
Phase 1b, Open Label, REC-617, RB1-Negative, Leiomyosarcoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07633756

Phase 1, Recruiting
Active & Responsive

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

for
Glioblastoma Multiforme (GBM),
Location: Houston TX
Sponsor: Radiomedix, Inc.

Sex: All

Age: 18+

Code: NCT07733674

Phase 1, Recruiting
Active & Responsive

Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma

for
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT07673367

Phase 2, Recruiting
Active & Responsive

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

for
Human Papilloma Virus, Anal Dysplasia, HIV
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: Male

Age: 18 - 70

Code: NCT06624839

Phase 2, Recruiting
Active & Responsive

Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma

for
Multiple Myeloma (MM)
Location: Maywood IL, Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT07236502

Recruiting
Active & Responsive

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

for
High-risk Muscle Invasive Urothelial Carcinoma
Location: Hamilton, Barrie
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07720284

Phase 3, Recruiting
Active & Responsive

AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas

for
Gastroesophageal Adenocarcinoma
Location: New Haven CT, Toronto, Houston TX, Los Angeles CA
Sponsor: American Association for Cancer Research

Sex: All

Age: 18+

Code: NCT07290985

Phase 2, Recruiting
Active & Responsive

PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

for
Coronary Artery Disease Risk Factors Multiple,
Location: Boston MA, New York NY, Charlottesville VA, Durham NC,
Sponsor: Duke University

Sex: All

Age: 30 - 60

Code: NCT07232069

Phase 3, Recruiting
Active & Responsive

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

for
Age-Related Macular Degeneration,
Location: Manchester CT, Beachwood OH, Lemont IL, Tyler TX,
Sponsor: i-Lumen Scientific AUS PTY LTD

Sex: All

Age: 60+

Code: NCT06662162

Recruiting

What is oncology?

Oncology is the branch of medicine focused on cancer. Cancer itself is not a single disease. It is a family of more than 100 diseases, from breast cancer and lung cancer to blood cancers like leukemia and lymphoma. What they share is the same basic problem: cells that grow and divide without stopping. About 4 in 10 people in the US will be diagnosed with some form of cancer during their lifetime.

Cancer research moves faster than almost any other field of medicine. Cancer drugs made up about 35% of all new FDA drug approvals in 2025, 16 new medicines in one year. The 5 year survival rate for all cancers combined reached 70% for people diagnosed in 2015 to 2021, a first in US history. And survival for metastatic (spread) cancer has doubled since the mid 1990s, from 17% to 35%. Every one of those gains came through clinical trials.

Who can participate in oncology trials?

Do oncology trial participants get paid?

Types of cancer clinical trials

The stages of cancer, and why they matter for trials

How to enroll in a clinical trial for cancer